Table 2.
Characteristics of patients with SLE for serum biomarker assessment
| Characteristic | SLE |
|---|---|
| N | 200 |
| Female, n, % | 182, 91% |
| Age, year (mean ± SD) | 38.06 ± 12.78 |
| SLEDAI (mean ± SD) | 12.55 ± 6.97 |
| CysC (mean ± SD) | 1.55 ± 0.94 |
| Proteinuria (> 0.5 g/24 h), n, % | 63, 31.5% |
| Hematuria, n, % | 76, 38% |
| Cylindruria, n, % | 11, 5.5% |
| Malar erythema, n, % | 5, 66.67% |
| Phontaesthesia, n, % | 2, 28.57% |
| Mucosal ulcers, n, % | 15, 7.5% |
| Lupus headache, n, % | 6, 3% |
| Arthritis, n, % | 94, 47% |
| Rash, n, % | 55, 27.5% |
| Pleurisy, n, % | 1, 0.5% |
| Pyuria, n, % | 69, 34.5% |
| Psychosis, n, % | 5, 2.5% |
| Fever, n, % | 72, 36% |
| Lupus encephalopathy, n, % | 1, 0.5% |
| Alopecia, n, % | 21, 10.5% |
| Low C3, n, % | 144, 72% |
| Anti-dsDNA antibody, n, % | 115, 57.5% |